# Efficacy & Safety of hADM Skin Booster

> **NCT07155278** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 20 (actual)

## Conditions studied

- Rhytides
- Skin Texture Irregularities
- Photoaged Facial Skin
- Skin Lifting and Tightening

## Interventions

- **DRUG:** Elravie Re2O
- **DRUG:** Elravie Balance

## Key facts

- **NCT ID:** NCT07155278
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-21
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-05-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155278, "Efficacy & Safety of hADM Skin Booster". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07155278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
